Germline pathogenic variants (GPVs) in melanoma susceptibility genes CDKN2A, CDK4, and BAP1 are identified in up to 40%, 0.7%, and 1.0% of familial melanoma cases, respectively.1 Here, CDKN2A is linked to melanoma.